Paris, France

Boussad Souttou

This inventor holds 1 USPTO granted patent. Top assignee: Georgetown University. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Boussad Souttou. Retrieved from https://idiyas.com/inventor/boussad-souttou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Boussad Souttou: Innovator in Pleiotrophin Detection

Introduction

Boussad Souttou is a notable inventor based in Paris, France. He has made significant contributions to the field of medical diagnostics, particularly in the detection of pleiotrophin. His innovative work has the potential to impact the diagnosis and treatment of pleiotrophin-positive diseases.

Latest Patents

Boussad Souttou holds a patent for a novel method and kit for detecting and measuring pleiotrophin in samples. This invention involves incubating a sample suspected of containing pleiotrophin with anti-pleiotrophin antibodies and determining the presence of pleiotrophin using a sandwich ELISA. Additionally, the patent provides methods for treating pleiotrophin-positive diseases by administering an anti-pleiotrophin antibody or fragment thereof. He has 1 patent to his name.

Career Highlights

Boussad Souttou is affiliated with Georgetown University, where he continues to advance research in his field. His work is characterized by a commitment to improving diagnostic methods and therapeutic approaches for diseases associated with pleiotrophin.

Collaborations

He has collaborated with notable colleagues such as Anton Wellstein and Daniel Raulais, contributing to a rich environment of innovation and research.

Conclusion

Boussad Souttou's contributions to the detection of pleiotrophin highlight his role as an important figure in medical innovation. His work not only enhances diagnostic capabilities but also opens avenues for new treatment strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…